Your session is about to expire
← Back to Search
Behavioural Intervention
HealthBeacon Injection Care Management System (ICMS) Arm for Respiratory Diseases
N/A
Waitlist Available
Led By Brian Modena, Dr
Research Sponsored by HealthBeacon Plc
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
Study Summary
This trial assesses the suitability of HealthBeacon ICMS for respiratory patients, to help them manage their medications at home and increase adherence.
Eligible Conditions
- Respiratory Diseases
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Outcome of billing for the HealthBeacon Injection Care Management System (ICMS) under Remote Therapeutic Monitoring (RTM) reimbursement codes
Secondary outcome measures
Compliance Data
Participant Feedback
Physician Feedback
Trial Design
1Treatment groups
Experimental Treatment
Group I: HealthBeacon Injection Care Management System (ICMS) ArmExperimental Treatment1 Intervention
All participants enrolled will be recruited to this study arm and provided with access to the HealthBeacon ICMS.
Find a Location
Who is running the clinical trial?
HealthBeacon PlcLead Sponsor
1 Previous Clinical Trials
150 Total Patients Enrolled
Modena Allergy & AsthmaUNKNOWN
Brian Modena, DrPrincipal InvestigatorPrincipal Investigator
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: HealthBeacon Injection Care Management System (ICMS) Arm
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is there space available for participants in this trial?
"Affirmative. Clinicaltrials.gov presents evidence that this experiment is actively seeking volunteers, having first been posted on November 1st 2022 and last updated 28 days later. A total of 10 candidates are needed at a single study site."
Answered by AI
To what extent is this study recruiting participants?
"Affirmative. On clinicaltrials.gov, the information points to this trial's active recruitment of participants starting from November 1st 2022 and ending on November 28th 2022; 10 individuals are being sought after at a single medical center."
Answered by AI
Share this study with friends
Copy Link
Messenger